144 related articles for article (PubMed ID: 29072095)
1. In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells.
Marasovic M; Ivankovic S; Stojkovic R; Djermic D; Galic B; Milos M
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1299-1304. PubMed ID: 29072095
[TBL] [Abstract][Full Text] [Related]
2. Impact of calcium ion on cytotoxic effect of the boroxine derivative, K
Ivankovic S; Stojkovic R; Maksimovic M; Galic B; Milos M
J Enzyme Inhib Med Chem; 2016; 31(sup3):70-74. PubMed ID: 27389366
[TBL] [Abstract][Full Text] [Related]
3. Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody.
Shanker A; Brooks AD; Tristan CA; Wine JW; Elliott PJ; Yagita H; Takeda K; Smyth MJ; Murphy WJ; Sayers TJ
J Natl Cancer Inst; 2008 May; 100(9):649-62. PubMed ID: 18445820
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium-trioxohydroxytetrafluorotriborate (K2[B3O3F4OH]).
Ivankovic S; Stojkovic R; Galic Z; Galic B; Ostojic J; Marasovic M; Milos M
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):354-9. PubMed ID: 24939106
[TBL] [Abstract][Full Text] [Related]
5. Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis.
Yin SY; Jian FY; Chen YH; Chien SC; Hsieh MC; Hsiao PW; Lee WH; Kuo YH; Yang NS
Nat Commun; 2016 Apr; 7():11311. PubMed ID: 27089063
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer.
Lei M; Feng H; Bai E; Zhou H; Wang J; Qin Y; Zhang H; Wang X; Liu Z; Hai O; Liu J; Zhu Y
Org Biomol Chem; 2019 Jan; 17(3):683-691. PubMed ID: 30601533
[TBL] [Abstract][Full Text] [Related]
7. In vivo antitumour properties of tribenzyltin carboxylates in a 4T1 murine metastatic mammary tumour model: Enhanced efficacy by PLGA nanoparticles.
Anasamy T; Chee CF; Kiew LV; Chung LY
Eur J Pharm Sci; 2020 Jan; 142():105140. PubMed ID: 31704345
[TBL] [Abstract][Full Text] [Related]
8. Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.
Smith YE; Toomey S; Napoletano S; Kirwan G; Schadow C; Chubb AJ; Mikkelsen JH; Oxvig C; Harmey JH
BMC Cancer; 2018 Oct; 18(1):1016. PubMed ID: 30348128
[TBL] [Abstract][Full Text] [Related]
9. 4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo: comparison with tirapazamine.
Papadopoulou MV; Ji M; Rao MK; Bloomer WD
Oncol Res; 2001; 12(8):325-33. PubMed ID: 11589303
[TBL] [Abstract][Full Text] [Related]
10. Murine breast carcinoma 4T1 cells are more sensitive to atranorin than normal epithelial NMuMG cells in vitro: Anticancer and hepatoprotective effects of atranorin in vivo.
Solár P; Hrčková G; Koptašíková L; Velebný S; Solárová Z; Bačkor M
Chem Biol Interact; 2016 Apr; 250():27-37. PubMed ID: 26969521
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic and preventive effects of an epidermal growth factor receptor inhibitor on oral squamous cell carcinoma.
Ge H; Liu H; Fu Z; Sun Z
J Int Med Res; 2012; 40(2):455-66. PubMed ID: 22613406
[TBL] [Abstract][Full Text] [Related]
12. A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A(2) inhibitor, displays antitumour activity.
Donnini S; Finetti F; Francese S; Boscaro F; Dani FR; Maset F; Frasson R; Palmieri M; Pazzagli M; De Filippis V; Garaci E; Ziche M
Biochem J; 2011 Dec; 440(2):251-62. PubMed ID: 21834793
[TBL] [Abstract][Full Text] [Related]
13. A Petiveria alliacea standardized fraction induces breast adenocarcinoma cell death by modulating glycolytic metabolism.
Hernández JF; Urueña CP; Cifuentes MC; Sandoval TA; Pombo LM; Castañeda D; Asea A; Fiorentino S
J Ethnopharmacol; 2014 May; 153(3):641-9. PubMed ID: 24637191
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.
Fernandez-Pol JA; Klos DJ; Hamilton PD
Anticancer Res; 1993; 13(1):57-64. PubMed ID: 8476229
[TBL] [Abstract][Full Text] [Related]
15. Phenylboronic Acid-Mediated Tumor Targeting of Chitosan Nanoparticles.
Wang X; Tang H; Wang C; Zhang J; Wu W; Jiang X
Theranostics; 2016; 6(9):1378-92. PubMed ID: 27375786
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma.
Luo KW; Yue GG; Ko CH; Lee JK; Gao S; Li LF; Li G; Fung KP; Leung PC; Lau CB
Phytomedicine; 2014; 21(8-9):1078-87. PubMed ID: 24856767
[TBL] [Abstract][Full Text] [Related]
17. Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer.
Moase EH; Qi W; Ishida T; Gabos Z; Longenecker BM; Zimmermann GL; Ding L; Krantz M; Allen TM
Biochim Biophys Acta; 2001 Feb; 1510(1-2):43-55. PubMed ID: 11342146
[TBL] [Abstract][Full Text] [Related]
18. The proteasome inhibitor PS-341 in cancer therapy.
Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J
Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643
[TBL] [Abstract][Full Text] [Related]
19. Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in mice.
Huang CC; Lo CP; Chiu CY; Shyur LF
Br J Pharmacol; 2010 Feb; 159(4):856-71. PubMed ID: 20105176
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib is ineffective in an orthotopic mouse model of pancreatic adenocarcinoma.
Märten A; Zeiss N; Serba S; Mehrle S; von Lilienfeld-Toal M; Schmidt J
Mol Cancer Ther; 2008 Nov; 7(11):3624-31. PubMed ID: 19001444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
